Who is sponsoring NCT00268788?

NCT00268788 is sponsored by University of Aarhus.

What drugs are being tested in NCT00268788?

Interventions in NCT00268788: Subcutaneous immunoglobulin, Intravenous immunoglobulin.

What condition does NCT00268788 study?

NCT00268788 studies Multifocal Motor Neuropathy.

Is NCT00268788 still recruiting?

NCT00268788 is currently completed. Last updated 19 February 2008.

Last reviewed 2008-02-19 · How we verify

NCT00268788

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Controlled Cross-Over Trial of Subcutaneous Versus Intravenous Immunoglobulin for Multifocal Motor Neuropathy

Completed Phase 2 Last updated 19 February 2008

What this trial tests

Phase 2 trial testing Subcutaneous immunoglobulin in Multifocal Motor Neuropathy in 10 participants. Completed in 1 February 2008.

Timeline

1 August 2005

Primary endpoint
1 February 2008

1 February 2008

Quick facts

Lead sponsor	University of Aarhus
Phase	Phase 2
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	single
Primary purpose	treatment
Enrollment	10
Start date	1 August 2005
Primary completion	1 February 2008
Estimated completion	1 February 2008
Sites	1 location across Denmark

Drugs / interventions tested

Subcutaneous immunoglobulin — full drug profile →
Intravenous immunoglobulin — full drug profile →

Conditions studied

Multifocal Motor Neuropathy — all drugs for Multifocal Motor Neuropathy →

Sponsor

University of Aarhus

Who can join

Adults 18 to 80, any sex, with Multifocal Motor Neuropathy. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Isokinetic muscle strength at the three most affected muscle groups.
Time frame: At the end of each arm of the crossover study

Sponsor's own description

The purpose of this study is to evaluate the effect of subcutaneous administration of immunoglobulin compared to intravenous treatment, for multifocal motor neuropathy NB. ONLY RECRUITING FROM DENMARK

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Immunoglobulin for multifocal motor neuropathy.
Keddie S, Eftimov F, van den Berg LH, Brassington R, et al · · 2022 · cited 20× · PMID 35015296 · DOI 10.1002/14651858.cd004429.pub3
Comparison of routes for achieving parenteral access with a focus on the management of patients with Ebola virus disease.
Ker K, Tansley G, Beecher D, Perner A, et al · · 2015 · cited 10× · PMID 25914907 · DOI 10.1002/14651858.cd011386.pub2
Patient-reported preferences for subcutaneous or intravenous administration of parenteral drug treatments in adults with immune disorders: a systematic review and meta-analysis.
Bril V, Lampe J, Cooper N, Kiessling P, et al · · 2024 · cited 6× · PMID 39115099 · DOI 10.57264/cer-2023-0171

Verify or expand the search:

Other recruiting trials for Multifocal Motor Neuropathy

Currently open trials in the same condition.

NCT06537999 — A Clinical Study to Evaluate DNTH103 in Adults With Multifocal Motor Neuropathy · Phase 2 · recruiting
NCT05988073 — A Prospective Longitudinal Study in Adults With Multifocal Motor Neuropathy · active not recruiting
NCT06040567 — Polyneuropathy, Impairments and Physical Activity - The PolyImPAct Study · recruiting

Other University of Aarhus trials

Trials by the same sponsor.

NCT07209540 — European LUpuS Inception-Cohort Developing initiATivE · not yet recruiting
NCT07317401 — Investigating the Effects of Intermittent Hypoxia-Hyperoxia Treatment (IHHT) in People With Post-Viral Myalgic Encephalo · NA · not yet recruiting
NCT07531966 — Vascular Complications After Kidney Transplantation · recruiting
NCT07528339 — Prospective RegIstry for Oncologic Reirradiation (PRIOR-DK) · not yet recruiting
NCT07451028 — Effect of an Oral Neuromuscular Training Device on Dysphagia · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT00268788 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Aarhus
Last refreshed: 19 February 2008

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00268788.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing